Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-27

Clinical Trial Update: Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vestibular Vertigo in Routine Practice

View source ↗

Summary

This clinical trial update assesses the effectiveness of Betaserc (betahistine dihydrochloride) for vestibular vertigo in routine practice; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betaserc (betahistine)

Snippet

Sponsor: Abbott | Conditions: Vertigo | Status: COMPLETED | Results posted: 2015-02-27